BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 425591)

  • 1. [Correlations between the diminished secretion of export proteins from the liver and the plasmatic activity of liver cell enzymes (author's transl)].
    Lautz HU; Schmidt E; Schmidt FW; Barthels M
    Z Gastroenterol; 1979 Feb; 17(2):99-105. PubMed ID: 425591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Summary of work session 1: Blood coagulation in gastroenterology].
    Bredden K; Lechner K
    Z Gastroenterol; 1976 Mar; 14 Suppl():202-10. PubMed ID: 785839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
    Erem C
    Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased activity of vitamin K-dependent clotting factors in human hyperlipoproteinaemia - association with cholesterol and triglyceride levels.
    Constantino M; Merskey C; Kudzma DJ; Zucker MB
    Thromb Haemost; 1977 Aug; 38(2):465-74. PubMed ID: 579489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lecithin:cholesterol acyltransferase as a component of enzyme patterns in acute and chronic liver disease. A preliminary report.
    Lautz HU; Schmidt E; Barthels M; Kiessler G
    Scand J Clin Lab Invest Suppl; 1978; 150():183-6. PubMed ID: 746346
    [No Abstract]   [Full Text] [Related]  

  • 6. Liver tissue lecithin: cholesterol acyltransferase activity in patients with liver disease.
    Ras MR; Frison JC; Rubies-Prat J; Romero R; Masdeu S; Schwartz S
    Biomedicine; 1977 Jun; 27(4):141-3. PubMed ID: 890021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative estimation of coagulation factors in liver disease. The diagnostic and prognostic value of factor XIII, factor V and plasminogen.
    Biland L; Duckert F; Prisender S; Nyman D
    Thromb Haemost; 1978 Jun; 39(3):646-56. PubMed ID: 705694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Alterations of hemostasis in liver cirrhosis of the dog].
    Mischke R; Pöhle D; Schoon HA; Fehr M; Nolte I
    Dtsch Tierarztl Wochenschr; 1998 Feb; 105(2):43-7. PubMed ID: 9528205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of coagulation proteins as acute-phase reactants in horses with colic.
    Topper MJ; Prasse KW
    Am J Vet Res; 1998 May; 59(5):542-5. PubMed ID: 9582953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Serum cholinesterase activity (CHE) in different classes of chronic liver diseases (author's transl)].
    Galanti B; Russo M; Nardiello S; Guarino F
    Quad Sclavo Diagn; 1978 Mar; 14(1):95-102. PubMed ID: 746115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The relationship between hemostatic changes in liver cirrhosis patients with different degrees of liver lesions in reference to Child-Pugh scores].
    Cong YL; Wei YX; Zhang LW; Yin ZJ; Bai J
    Zhonghua Gan Zang Bing Za Zhi; 2005 Jan; 13(1):31-4. PubMed ID: 15670488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Enzyme diagnosis of liver diseases].
    Weber H
    Hippokrates; 1969 Dec; 40(23):904-7. PubMed ID: 5396918
    [No Abstract]   [Full Text] [Related]  

  • 13. [Intracranial hemorrhage and hemostasis. Monitoring patients after intracranial hemorrhage by determination and follow-up of activation products of blood coagulation].
    Menges T; von Lessen A; Welters I; Wagner RM; Ruwoldt R; Boldt J; Hempelmann G
    Infusionsther Transfusionsmed; 1994 Aug; 21(4):244-50. PubMed ID: 7950289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemostatic problems in liver surgery.
    Rö JS
    Scand J Gastroenterol Suppl; 1973; 19():71-81. PubMed ID: 4577801
    [No Abstract]   [Full Text] [Related]  

  • 15. Formation of the fibrin clot: the balance of procoagulant and inhibitory factors.
    Lämmle B; Griffin JH
    Clin Haematol; 1985 Jun; 14(2):281-342. PubMed ID: 2994929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coagulation changes during massive hepatic necrosis due to Amanita phalloides poisoning with special reference to antihemophilic globulin.
    Meili EO; Frick PG; Straub PW
    Helv Med Acta; 1970 Oct; 35(4):304-13. PubMed ID: 5507041
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical and prognostic role of plasma coagulation factor XIII activity for bleeding disorders and 6-year survival in patients with chronic liver disease.
    Tacke F; Fiedler K; von Depka M; Luedde T; Hecker H; Manns MP; Ganser A; Trautwein C
    Liver Int; 2006 Mar; 26(2):173-81. PubMed ID: 16448455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Serum enzyme activity in liver and biliary tract diseases].
    Gerlach U
    Curr Probl Clin Biochem; 1968; 1():165-96. PubMed ID: 4950595
    [No Abstract]   [Full Text] [Related]  

  • 19. [Biostatistical analysis used in the physiopathological evaluation of serum alcohol dehydrogenase in liver diseases: preliminary results].
    Di Simone A; Riegler G; Oriani GA; Coltorti M
    Boll Soc Ital Biol Sper; 1974 Sep; 50(18):1501-4. PubMed ID: 4458735
    [No Abstract]   [Full Text] [Related]  

  • 20. [Coagulation studies in liver diseases of children].
    Tschäppeler H; Gugler E
    Z Kinderheilkd; 1968; 103(4):349-64. PubMed ID: 5688626
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.